NKCx Histopathological outcome* within 12 months after cervix cytology in 2021
411 Lund

  Benign LSIL HSIL AIS Cancer Other PAD missing Total
Cytologi Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel
Benign sample 1499 5.2% 79 0.3% 7 0.0% 4 0.0% 6 0.0% 29 0.1% 27007 94.3% 28631 100.0%
ASCUS 1532 32.6% 569 12.1% 156 3.3% 4 0.1% 1 0.0% 95 2.0% 2348 49.9% 4705 100.0%
LSIL 889 25.7% 913 26.4% 288 8.3% 5 0.1% 1 0.0% 99 2.9% 1266 36.6% 3461 100.0%
Atypical glandular cells/AGC 63 41.2% 11 7.2% 2 1.3% 14 9.2% 2 1.3% 6 3.9% 55 35.9% 153 100.0%
Unclear atypia 17 43.6% 3 7.7% 1 2.6% 1 2.6% . . 2 5.1% 15 38.5% 39 100.0%
ASC-H 92 17.0% 123 22.7% 281 51.8% 7 1.3% 5 0.9% 7 1.3% 27 5.0% 542 100.0%
HSIL 44 7.1% 45 7.3% 462 74.5% 19 3.1% 16 2.6% 12 1.9% 22 3.5% 620 100.0%
Suspected Adenocarcinom 5 9.8% 1 2.0% . . 24 47.1% 11 21.6% 2 3.9% 8 15.7% 51 100.0%
Adenocarcinoma . . . . . . . . . . . . 2 100.0% 2 100.0%
Malignant tumor with unclear origin . . . . 2 25.0% . . 5 62.5% 1 12.5% . . 8 100.0%
Squamous cell cancer . . 1 5.3% 4 21.1% . . 12 63.2% . . 2 10.5% 19 100.0%
Totalt 4141 10.8% 1745 4.6% 1203 3.1% 78 0.2% 59 0.2% 253 0.7% 30752 80.4% 38231 100.0%

NOTE: Histopathological outcome from T83x taken into account.
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad.

* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead.
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'.
Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories.
 

Snomed codes in the category Cancer:
M69760, M80001, M80009, M80703, M80706, M81403, M81409, M83803, M83806, M84613, M89313